KYMR Cash & Equivalents

Kymera Therapeutics Inc · Cash & Equivalents

KYMR logo

KYMR Cash & Equivalents

Latest reported$357.01M
KYMR FY Cash & Equivalents ($41.26M → $357.01M)
High-resolution chart · PNG

KYMR cash & equivalents history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Kymera Therapeutics Inc Cash & Equivalents — Annual fiscal periods (USD)
Period endingCash & Equivalents (USD)
357,011,000
120,256,000
109,966,000
68,395,000
47,976,000
31,004,000
76,015,000
41,260,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.